A New HOPE? Lessons from Heart Outcomes Prevention Evaluation-3

Lifestyle modification is the cornerstone of preventing atherosclerotic cardiovascular disease. When this is not sufficient in reducing risk, statin therapy is first line. Heart Outcomes Prevention Evaluation (HOPE-3) was a randomized controlled trial of rosuvastatin versus placebo, which demonstrat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of medicine 2018-02, Vol.131 (2), p.134-140
Hauptverfasser:	Howard, Travis M., Bavishi, Aakash A., Stone, Neil J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adherence Atherosclerosis - ethnology Atherosclerosis - prevention & control Cardiovascular Diseases - ethnology Cardiovascular Diseases - prevention & control Female Healthy Lifestyle HOPE-3 Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Legacy effect Male Medication Adherence Primary Prevention Randomized controlled trial Randomized Controlled Trials as Topic Risk Factors Rosuvastatin Calcium - therapeutic use Sex Factors Statin Women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!